Profile
Corporate information
Official name
SV Health Investors LLP
Registration country
Official name
SV Health Investors LLP
Registration country
Investment activity status
Active investor
Funds managed
Fund | Type | Vintage |
---|---|---|
SV Fund VI | Venture |
Investments
Selected investments
Company | Country | Notes | ||
---|---|---|---|---|
Versicor |
N/A Initial investment. Round participant. Exited |
|||
Strides Arcolab |
N/A Initial investment. Round participant. Exited |
|||
Sadra Medical Inc |
United States | N/A Initial investment. Round participant. Exited |
||
Physicians Dialysis Inc |
United States | N/A Initial investment. Round participant. Exited |
||
OMS Foundations |
N/A Initial investment. Round participant. Exited |
|||
Mindframe Inc |
United States | N/A Initial investment. Round participant. Exited |
||
Leukosite Inc Developer of small molecule and monoclonal antibody therapeutics for inflammatory, autoimmune, and viral diseases, as well as for cancer applications. |
United States | N/A Initial investment. Round participant. Exited |
||
Insulet Corp |
United States | N/A Initial investment. Round participant. Exited |
||
GlycoFi Inc |
N/A Initial investment. Round participant. Exited |
|||
ESBATech AG Switzerland based Biomedical Research Unit of Alcon |
Switzerland | N/A Initial investment. Round participant. Exited |
||
Coral Therapeutics |
N/A Initial investment. Round participant. Exited |
|||
ValenTx Inc Developer of a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. |
United States | N/A Initial investment. Round participant. Exited |
||
Stimwave Technologies Inc Provider of wireless microsize injectable medical devices for neurology markets. |
United States | N/A Initial investment. Round participant. Exited |
||
Rinat Neuroscience Corp Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases |
United States | N/A Initial investment. Round participant. Exited |
||
Phase Forward Inc |
United States | N/A Initial investment. Round participant. Exited |
||
Ocular Therapeutix Inc A medical device company that is currently engaged in the development of in situ formed hydrogel therapeutic products specifically for ophthalmology. |
United States | N/A Initial investment. Round participant. Exited |
||
Micromet Inc Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases |
United States | N/A Initial investment. Round participant. Exited |
||
LensX Lasers Inc |
United States | N/A Initial investment. Round participant. Exited |
||
Incyte Pharmaceuticals |
N/A Initial investment. Round participant. Exited |
|||
Genosis PLC Delivering innovative and unique solutions to consumer issues arising in the field of reproductive health |
United Kingdom | N/A Initial investment. Round participant. Exited |